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INTRODUCTION 
 The thyroid gland is an endocrine gland situated in the lower part 
of front and the sides of the neck. Its main function is regulation of the 
basal metabolic rate, stimulates somatic and psychic growth and plays 
important role in calcium metabolism. The term thyroid is derived from 
Greek, which means shield (Thyros –shield, eidos – form).Normal 
thyroid gland is impalpable.  Thyroid gland enlargement is the most 
common manifestation of the thyroid disease. The enlargement may be 
either generalized or localized, which again may be, toxic or nontoxic. 
The nontoxic goitre is further divided on etiological basis as endemic 
goitre and sporadic goitre. The endemic goitre is defined as one where 
more than 10% of population shows thyroidenlargement.1 Diseases of 
thyroid gland especially multinodular goitre due to deficiency of iodine 
are prevalent in India. Though exact incidence of nodular goitre is not 
available, WHO, in 1958, estimated that goitre was present in 200 
million, which represented 7% of World’s population at that time. 
Nodular goitres are more common in women than in men and the 
nodularity increases with increasing age. Multinodular goitres (MNG) 
can become malignant but it is rare. 
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AIMS AND OBJECTIVES  
¾ TO   STUDY  AGE  AND    SEX   DISTRIBUTION  
¾ TO  KNOW  VARIOUS  MODES  OF   CLINICAL  
PRESENTATION  
¾ TO  COMPARE  AND  CORRELATE   THE  FINDINGS  OF  
INVESTIGATIONS   WITH  THE  HISTOPATHOLOGY   OF  
RESECTED   SPECIMEN 
¾ TO  KNOW  THE  INCIDENCE  OF  MALIGNANCY  IN 
MULTINODULAR  GOITRE 
¾ TO STUDY THE  PRINCIPLES  AND  MANAGEMENT  OF  
MULTINODULAR  GOITRE 
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REVIEW OF LITERATURE 
HISTORY2, 3 
 The thyroid gland was previously referred to as a laryngeal gland 
and was subsequently named thyroid by Wharton in 1645, because of 
thyroid cartilage with which it is closed associated. Existence of thyroid 
gland was known to Galen (2 A.D), who thought that it provided fluid for 
lubrication of larynx. Sir Astley Cooper (1768-1841) said it has the 
function of secretion. Thyroxine (T4) was isolated by Kendall in 1965 and 
it was synthesized by theHarrington and Banger in 1927. In 1953 the 
important discovery of 3, 5, 3 Tri-iodothyronine was made by Cross and 
Pitt-rivers and by Roche, Liesitsky and Michel simultaneously. This was 
proved to be more effective than thyroxine itself. With the introduction of 
radioactive iodine in 1934, it was possible for the clear understanding of 
thyroid physiology. In 1986 Bouman discovered Iodine in considerable 
amount in thyroid gland. Iodine was first identified by French Chemist 
Courtisis in 1812 who found it in ash of burnt seaweed. But Chatin during 
1850-1876 was the first to conclude iodine deficiency as a principle cause 
of goitre. Experimental goitre was produced by Chesney (1888) by John 
Hopkins University in Rabbits, by feeding them with cabbage and 
established, cabbage as one of the goitrogenic agents. Potassium 
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thiocyanate was found to produce goitre, in some of the hypertensive 
patients. Paracelsus (1492-1541) showed relationship between endemic 
goitre and cretinism. In 1850 Curling, a Surgeon at London hospital gave 
account of cretinism in two children and recorded complete absence of 
thyroid gland at postmortem in both the cases. Gull in 1874 described 
cretinoid change in adults. In 1878 Ord suggested the term Myxoedema 
to describe the condition occurring after total or partial thyroidectomy. 
EARLY OPERATIONS: 
 The first credible account of thyroid surgery was given in 1170, by 
Roger Frugardi of Salerno, in the Bamberg manuscripts. Goitres which 
failed to respond were removed by finger dissection, insertion of setons, 
ligation en masse, and application of caustic powder. All such procedures 
were liable to major complications and increased mortality. The first 
well-documented partial thyroidectomy was undertaken in Paris in1791 
by Pierre Joseph Desault (1744-1795), during the terror of French 
Revolution.Guillaume Dupuytren (1777-1835) also in Paris, undertook 
total thyroidectomy in 1808 for a Goitre weighing 1.2 kgs, but the patient 
died. In 1821, Johann Hedenus (1760-1836) of Dresden, successfully 
removed six “suffocating goitre”, by dissection and ligation of all the 
arteries. This achievement was not equalled for next forty years. The 
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results of most thyroid operations were disastrous until the second half 
of19th century. Bleeding, which could not be controlled, and sepsis, 
cause of which was not known, often proved fatal. 
 By the 19th century the usual indications for surgery were 
suffocation and dysphagia. The overall mortality was over 40% and many 
surgeons advised against operating on goitres and considered it as one of 
the most thankless, most perilous undertakings. The advances, which 
followed the advent of general anaesthesia (1840’s), antisepsis (1860’s) 
and haemostasis (1870’s), enabled surgeons to undertake more thyroid 
operations, and device new ones, with greatly reduced mortality. Between 
1850 and 1977, the world wide operative mortality fell to around 20%. 
 The leading thyroid surgeons at this time were Theodor Kocher 
(1841-1917) and Theodor Billroth (1829-1894). Both of them performed 
thousands of thyroidectomies, with progressively better results. By 1883, 
operative mortality had fallen to 12% and by the end of the century to 
3%.Theodor Kocher was Professor of Surgery in Berne, Switzerland. 
Kocher operated on more than 500 patients. He advocated gentle 
meticulous surgery that spared yet to be discovered parathyroid glands 
and anatomical appreciation of recurrent laryngeal nerve. With 
application of these principles mortality of thyroid surgery decreased 
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from more than 59% to approximately 0.2%. Even more important was 
the discovery by Kocher that total thyroidectomy was followed by 
development of myxoedema and he demonstrated that this complication 
could be prevented by subtotal thyroidectomy. For this work in medical 
understanding and care in diseases of thyroid gland Kocher was awarded 
Nobel Prize in 1909. THEODER KOCHER IS REGARDED AS 
FATHER OF THYROID SURGERY. Because operations were now safe, 
many goitres were removed mainly for cosmetic reasons. Usually general 
anaesthesia with ether or chloroform was used; but local anaesthesia with 
cocaine was sometimes used. The Collar incision introduced by Tules 
Boeckel (1848-1927) of Strasbourg was adopted widely. Europe was the 
Cradle of thyroid Surgery in 19th century. In 1890’s American Surgeons 
visited the main European centres and began to make important 
contributions in the early twentieth century. Notable among these were 
Halsted, Charles Maya (1865-1939) and George Crile (1864-1943). The 
indications of operation were extended to include the prevention of 
complications, especially in patients with thyrotoxicosis and thyroid 
cancer. The latter was sometimes an unexpected discovery after 
operation. For this reason total lobectomy with removal of the isthmus 
and pyramidal lobe came to be used. This reduced the need for further 
operations when malignancy was found. The first transplantation of 
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thyroid was recorded by Payr in 1906. He transplanted a portion of the 
thyroid gland from a woman into the spleen of her myxoedemic daughter. 
 Following the development of non-surgical measures to manage 
most cases of hyperthyroidism and colloid goitre due to availability of 
radioactive iodine, antithyroid drugs and iodination of salt, surgical 
attention was directed to nodules, both benign and malignant but with 
emphasis on the latter. In the 1940’s and 1950’s, attempts were initiated 
to determine the frequency of carcinoma producing thyroid nodules and 
criteria for operation for thyroid nodules. Thyroid scans using I131 became 
available and assumed a frequently used role in identifying hypo 
functional nodules. However it soon became evident that this procedure 
was of little help in separating the malignant from the numerous benign 
thyroid nodules. With the development of techniques such as FNAC and 
ultrasound, the performance of thyroidectomy has become selective, 
unlike in the past when surgery was recommended for nearly all 
multinodular goitres. 
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DEVELOPMENT OF THYROID GLAND 1 
 Thyroid gland is developed from median endodermal thyroid 
diverticulum, which grows down in front of the neck from the floor of 
“primitive pharynx”, just caudal to tuberculum impar. The lower end of 
the diverticulum enlarges to form the gland. The rest of the narrow part of 
the diverticulum is known as thyroglossal duct, most of which disappears. 
The site of origin of diverticulum is seen as a depression called foramen 
caecum4 and the lower end often persists as pyramidal lobe. Thyroid is 
the earliest glandular structure to appear. It becomes functional during the 
third month of development of fetus. 
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SURGICAL ANATOMY OF THYROID GLAND5,6,7,8,9 
 
pretracheal lymph nodes 
 
 
 The thyroid gland is composed of two lobes connected by an 
isthmus and appears butterfly shape. The lobular extension is from the 
middle of thyroid cartilage to the sixth ring of trachea. The gland lies 
against 5th, 6th, 7th cervical and 1st thoracic vertebrae and the isthmus 
covers 2nd, 3rd and 4th tracheal rings. Rarely, aberrant and ectopic 
thyroids are found in stomach and ovaries. 
 10
WEIGHT AND DIMENSIONS 
 Thyroid gland averagely weighs 20-25 Gms. It is larger in females 
than in males and increases further during pregnancy and menstruation. 
Each lobe measures 2x1x1 inches and isthmus 1x1 inch. 
THYROID CAPSULES 
 Two capsules surround the gland namely true and false capsule. 
Peripheral condensation of connective tissues of the gland is the true 
capsule and false capsule is derived from pretracheal layer of deep 
cervical fascia. These two capsules are pierced by blood vessels of the 
thyroid and ramify to form dense plexus immediately beneath, the true 
capsule. Arterial and venous trunks traverse the space between the two 
capsules. So during surgery of the gland, these main vessels are secured 
between the two capsules, taking care not to damage true capsule. So the 
thyroid gland is removed with its true capsule. 
ANATOMICAL RELATIONS OF THYROID GLAND5 
 Each thyroid is conical in shape with an apex, base, two borders – 
anterior and posterior, three surfaces – superficial, medial and 
posterolateral. Apex is directed laterally and upwards and is limited by 
the attachment of sternothyroid on thyroid cartilage. Base is at the level 
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of 5th or 6th tracheal rings; anterior border is thin and is related to 
branches of superior thyroid artery. Posterior border is thick and rounded 
9 and is related to the inferior thyroid artery, parathyroid gland and 
thoracic duct on the left side. Superficial surface is covered by 
sternothyroid, sternohyoid and superior belly of omohyoid and anterior 
border of sternomastoid overlapping it inferiorly. The surface is convex. 
Two tubes, trachea and oesophagus, two muscles, inferior constrictor and 
cricothyroid and two nerves, External laryngeal and recurrent laryngeal 
nerves are related to the medial surface of thyroid gland. Posterior surface 
is related to carotid sheath and overlaps the common carotid artery. The 
isthmus has two surfaces and two borders. Occasionally it may be absent. 
Anterior surface of isthmus is covered by sternothyroid, sternohyoid 
muscles and anterior jugular vein. The upper border is related to the 
anastomotic branches of the two superior thyroid arteries. At the lower 
border inferior thyroid vein leaves the gland. A small portion of the gland 
substance often projects upwards from the isthmus, generally to the left of 
the midline, as the pyramidal lobe. Separate masses of thyroid tissue 
called accessory thyroid gland are often found near the hyoid bone, in the 
tongue, in the superior mediastinum, or anywhere along the path of 
descent of the thyroglossal duct. 
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BLOOD SUPPLY OF THE THYROID GLAND 
 It is supplied by two arteries which carry sympathetic fibres with 
them and is drained by three veins. 
ARTERIAL SUPPLY 
 The thyroid gland is supplied by superior thyroid, inferior thyroid 
and sometimes with an arteria thyroidea ima.6 The superior thyroid artery, 
first branch of external carotid artery descends downwards and forwards 
in intimate relation with external laryngeal nerve. It enters the gland 
superficially. After piercing the pretracheal fascia, it divides into anterior 
and posterior branches. The anterior branch runs along the upper border 
of isthmus to anastomose with the fellow of the opposite side. The 
posterior branch descends along the posterior border to anastomose with 
ascending branch of inferior thyroid artery. The superior thyroid supplies 
upper 1/3 rd of lobe and upper ½ of isthmus. The inferior thyroid artery is 
a branch of thyrocervical trunk, which in turn is a branch of subclavian 
artery. It is related to the posterior surface of gland. During the course it 
passes behind the carotid sheath and middle cervical ganglion but in front 
of the vertebral vessels. Its terminal part is intimately related to recurrent 
laryngeal nerve. It divides into 4 to 5 branches and one ascending branch 
anastomoses with posterior descending branch of superior thyroid artery. 
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 The inferior thyroi  d artery supplies the lower 2/3rd of the lobe and 
lower ½ of isthmus with parathyroid glands. This makes a major share in 
thyroid blood supply. The thyroidea ima artery enters the lower part of 
the isthmus and arises from the arch of aorta, or bracheocephalic trunk, or 
right common carotid artery and supplies the isthmus. 
VENOUS DRAINAGE  
 From a venous plexus on the surface of the gland the superior 
thyroid vein follow superior thyroid artery and runs along the outer 
border of omohyoid to terminate in internal jugular vein. The middle 
thyroid vein is a short channel, which leaves the gland at its middle, 
crosses the common carotid artery to enter into internal jugular vein. It 
bleeds torrentially if torn during surgery due to its shortness. The inferior 
thyroid vein leaves the isthmus at its lower border, runs down in front of 
11 trachea to end in the innominate vein of same side. Sometimes both 
inferior thyroid veins may join the left innominate vein. 
LYMPHATIC DRAINAGE 
 Thyroid is richly drained by lymphatics. It has extensive 
intraglandular and intralobar lymphatics that encircle the thyroid follicle. 
The capsular lymphatics may cross –communicate with isthmus and that 
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of the opposite lobe. The gland is drained by two sets of medial and 
lateral channels. The medial ascending channels leave the upper border of 
isthmus and drain to the gland on the cricothyroid membrane that is, the 
prelaryngeal lymph nodes. The ascending lateral vessels leave the upper 
pole of the gland and run with superior thyroid artery to the deep cervical 
nodes. Descending lateral vessels pass from deep surface of the gland to 
small nodes placed on recurrent laryngeal nerve, called nodes of recurrent 
chain. 
NERVE SUPPLY 
 Sympathetic nerves are mainly derived from middle cervical 
ganglion and partly from superior and inferior cervical ganglion which 
accompany the thyroid arteries. 
MICROSCOPIC ANATOMY 
 The thyroid consists essentially a mass of more or less rounded 
follicles containing varying amounts of colloid. These follicles are lined 
by a single layer of cuboidal epithelium, which form the walls of the 
follicles. These follicles are arranged in subunits of 20-40 lobules each 
being supplied by an individual arteriole. These cells secrete Thyroxine 
(T4) and tri-iodothyronine (T3). The parafollicular or ‘C cells lie in 
between the follicles, which secrete calcitonin, which in turn promotes 
deposition of calcium salts in the skeleton. 12 
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NERVES RELATED TO THE THYROID GLAND 
 Two nerves, the external branch of superior laryngeal nerve and 
recurrent laryngeal nerve are in intimate relation with thyroid gland. So 
protection of these nerves is very important in thyroid surgery. The 
external laryngeal nerve, which supplies inferior constrictor and 
cricothyroid muscle, is in real danger while ligating the superior thyroid 
artery. The nerve descends just deep to the artery. The best way to avoid 
injury to the nerve is to ligate the upper pole of the gland with the vessel 
as close to the gland as possible. The recurrent laryngeal nerve is related 
to the posterior surface of the gland in intimate relation with inferior 
thyroid arteries. The nerve can be identified in a triangle formed by 
common carotid artery laterally, trachea medially, and thyroid lobe 
superiorly, which lies in between trachea and larynx. 
VARIATIONS IN POSITION OF RECURRENT LARYNGEAL 
NERVE 5 
1.  The nerve penetrates and traverses through the gland which is a 
dangerous position. 
2.  The nerve courses through the area of greatest adherence of the 
gland to larynx i.e ligament of Berry – Not in the gland but very 
near to it. 
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3.  Nerve situated safely in tracheo-oesophageal groove. 
4.  The nerve passes posterior to the joint between inferior cornu of 
thyroid cartilage and the cricoid cartilage. 
5.  Right nerve may not be recurrent in some cases, arising directly 
from vagus above the level of cricoid cartilage. These are 
associated with anomalous origin of right subclavian artery. 
PHYSIOLOGY OF THYROID HORMONES 10,11 
 The primary function of thyroid gland is the production of 
sufficient thyroid hormones for proper regulation of cellular metabolism 
throughout the body. 
IODINE METABOLISM 
 Iodine is taken in the form of Iodides sea fish; egg and milk are 
good dietary source of iodide. Dietary iodide is absorbed from upper 
gastrointestinal tract and carried as inorganic iodide in plasma. Normally 
thyroid, salivary glands and kidney compete for iodide but thyroid and 
kidney are the principal organs that compete for iodide. The adult man 
requires 0.14 mg of iodide per day and an adult female requires 0.10 mg. 
Growing children, pregnant and lactating women require more. The daily 
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requirement is met by balanced diet and drinking water, exception being 
hilly areas where food and water may be deficient in iodine. 
SYNTHESIS AND SECRETION OF THYROID HORMONES12 
The synthesis of thyroid hormones is divided into four steps: 
a) Iodine trapping 
 The thyroid traps the plasma iodine in the inorganic form. It is 
essentially an active process and stimulated by TSH. It is competitively 
inhibited by Thiocynates and perchlorates. 
b). Iodine binding 
 The inorganic iodide is oxidized to inorganic iodine at the thyroid 
follicular cells with the help of an enzyme peroxidase. Iodine combines 
with amino acid tyrosine in the globulin molecule within the follicular 
cells to form monoiodotyrosine and diiodotyrosine (MIT and DIT). This 
process is inhibited by Thiouracil group of antithyroid drugs and by PAS 
and chloroquine. 
c). Coupling 
 Thyroxine (T4) is formed by coupling of two molecules of DIT and 
Triiodothyronine (T3) by coupling of one molecule of each MIT and DIT. 
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The coupling reaction occurs at the Thyroglobulin molecule. They are 
oxidative reactions and need peroxidase enzyme. 
d). Hormonal release 
 Thyroglobulin is first taken up by thyroid follicular cells. Under the 
influence of TSH a protease acts on thyroglobulin to release T4, T3, MIT 
and DIT. MIT and DIT are de-iodinated within the cell and iodine is 
reutilized for iodinating globulin. From the follicular cells T4 and T3 
directly enters the circulation. On entering the circulation the thyroid 
hormones are largely bound to specific  protein called thyroxine-binding 
globulin (TBG), thyroxine binding albumin and thyroxine binding 
prealbumin (TBPA). This protein has got more affinity to Thyroxine than 
to the tri-iodothyronine .The protein bound iodine (PBI), which is about 
4-8 μg per 100 ml mainly, reflects plasma T4 level. A small amount of 
hormone remains free in the serum in equilibrium with the protein bound 
hormone and is biologically active. The free hormone is physiologically 
active and protein bound fraction acts as a reserve. Thyroid hormones are 
disposed by de-iodination 80% and 20% excreted in the stools. About 
40% of circulating T4 is converted to T3 peripherally called “Reverse T3”. 
This is inhibited by propranolol and glucocorticoids. 
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DIFFERENCES BETWEEN T3 AND T4 
 T3 has quicker onset of action and is effective in very small doses. 
The onset of action of T3 is within 6-8 hours and that of T4 is 4-14 days. 
After cessation of therapy the hormonal effect lasts for several days with 
T4 but vanishes quickly with T3. T3 is the more important physiological 
hormone and is also produced in the periphery by conversion from T4. 
Reverse T3 is an inactive form of T3. Mechanism of action of thyroid 
hormones – (Sterling)13. In normal levels, the thyroid hormones act at 
chromatin of molecules and stimulate synthesis of mRNA molecules. 
These later synthesize protein molecules including enzymes at cytoplasm, 
which has anabolic, growth promoting, and calorigenic actions. But in 
unphysiological higher concentrations they act at mitochondria and 
uncouple oxidative phosphorylation. Thus oxygen consumption and heat 
production is increased. 
EPIDEMIOLOGY3 
 The distribution of nodular goitre is worldwide. It has been 
estimated that atleast 200 million people have goitre in the world (Selvyn 
Tailor 1968). It occurs in all races in all climates and at all inhabitable 
altitudes. It occurs both endemically and sporadically and most of the 
endemic areas are mountainous. In India, it is said that about 9 million 
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people suffer from goitre. There is a goitre belt along the northern border 
of India extending from Kashmir and Jammu-eastwards along the 
southern valleys and foothills of Himalayas into Assam. The reputation 
for goitre is more formidable in this region than in any other regions in 
the world. Gilgit and Ladock area of Kashmir, the districts of Thehri, 
Kasauly, Ambala and Dehradun of Himachal Pradesh and low lying 
planes of UP (Districts of Barailly, Gunmdal, Baster and Gorakpur), the 
districts of Muzafarpur of Bihar and most of the areas of Assam and 
Nagahill area come under the above mentioned goitre belt, including the 
state of Rajasthan, along the banks of Narmada river and in M.P and 
Orissa (Ranchi and Surgia districts). The endemic goitre is prevalent in 
Southern India. There is an endemic area at Coimbatore and Nilgiri hills 
and some parts of Arcot in Chennai state. Hilly areas of Coorg are 
considered to be endemic in Karnataka. Conclusion of goitre 
subcommittee of the Medical Research Council of Great Britain on the 
mechanism of simple goiters is failure of the thyroid gland, to obtain a 
supply of iodine, sufficient to maintain its normal structure and function. 
The failure is usually brought about by an absolute environmental 
deficiency of iodine. It may be caused by factors, which interfere with 
availability of dietary iodine, in turn imposing an abnormal demand on 
the thyroid gland. 
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AETIOLOGY OF MULTINODULAR GOITRE 
 Marrine, a trained pathologist did brilliant studies on goitre. One of 
the most classical experiments in public health shows iodine as a 
prophylactic supplement. The recent introduction of tracer methods, 
urinary radioactive iodine and of technique of chromatography has 
provided fresh opportunities for an understanding of the aetiology and 
pathogenesis of nodular goitre. Marrine demonstrated an inverse 
relationship between iodine contents of the given gland and the degree of 
epithelial hyperplasia. Vanfallen berg and Mac lendon demonstrated an 
inverse relationship between the level of iodine in food and drinking 
water on one hand and the incidence of goitres on the other. The next 
phase of work on the iodine deficiency hypothesis relates to experimental 
production of thyroid lesion in animals. Identical with that of endemic 
goitre under conditions in which deficiency of iodine is the only 
etiological factor. Several diets consisting of natural food stuffs deficient 
in iodine have been shown to lead to hyperplasia of thyroid acini. The 
most recent phase in the study is with the use of radioactive iodine. The 
pioneering study of Stanburg in Argentina and followed by similar 
studies in India, Holland, Finland in Congo have yielded results, which 
are consistent with iodine deficiency hypothesis. 
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GOITROGENS 
 There is evidence that, two classes of goitrogenic compounds, 
Thiocynates and Thiouracil like substances exist in food habitually 
consumed by man and domestic animals. Thiocynates inhibit the 
concentration of iodine and synthesis of thyroid hormones. Clement was 
of the opinion that plant goitrogens are unlikely to be significant 
etiological factors. 
FACTORS OTHER THAN IODINE DEFICIENCY 
 There are two outstanding well-documented epidemics on which 
the observed features do not fit in with the iodine deficiency hypothesis. 
Clement has shown that school children in Southern Tasmania develop 
seasonal goitre even though they have preceding large iodine supplement.  
 This seasonal increase appears to coincide with the spring flush of 
postures and weeds. Strong evidence was presented to suggest that a 
goitrogen in milk from cow fed on such postures was the cause of thyroid 
enlargement. Boys and girls are equally affected unlike in epidemics 
where girls predominate. Italy’s Coster showed another exception to 
iodine deficiency hypothesis when he observed in several epidemics that 
iodine may be normal or elevated, PBI level within the normal range and 
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water and urinary iodine values, no different from non-endemic region. 
There is yet no explanation for this, but Coster stated that some strong 
ties were observed between endemic and epidemic goitres in this region. 
Thyroid nodule in children following therapy with I131 
 The development of thyroid nodule several years after treatment 
with I131 for hyperthyroidism has been described in 256 patients treated 
between 1943-53 in California Hospital. Thyroid nodules were 
discovered in 8 patients from 5 to 30 years, 6 patients were less than 18 
years at the time of radio iodine administration and 2 were 25 and 30 
years. Thus younger the patients, greater the chance of thyroid nodules 
developing from radioiodine therapy for thyrotoxicosis. At the time of 
development of nodules none had hypothyroidism, none received 
thyroxine. Nodules are originated in the focal hyperplastic and 
regenerated portions of lobules apparently due to prolonged TSH 
stimulation on the tissues still able to react. Pathogenic changes in the 
thyroid gland were found in number of marshalled people of Rongelap 
Island who were accidentally exposed to radioactive fallouts in 1954. 
Definite thyroid nodules were noted in all people, minor changes in 5 
others and hyperthyroidism in 2. All but one case occurred in most 
heavily exposed population who received 175 rads of whole body 
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radioactive burns of the skin of the fallout products and internal 
absorption fission products. In 200 individuals of control group, not 
exposed, no such abnormalities were found. In 55 children less than 10 
years of age, thyroid nodules developed. Radiation etiology of these cases 
appears to be certain, in view of the following facts. 
 Thyroid gland received a substantial dose of radiation from 
radioiodine and external gamma radiation. The incidence of nodule was 
high in exposed group and absent in unexposed group and the control 
population living in the same island. Increased sensitivity of children’s 
thyroid gland in the development of nodules from radiation exposure has 
been amply demonstrated. 
FAMILIAL GOITRES 
1.  Defect in iodine transport 
2.  Defect in organification failure to form organic iodine 
3.  Deficiency of enzymes 
•  Lack of iodine peroxidase – complete block 
•  Lack of iodine transferase – incomplete block, relatively common 
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 More than 150 cases reported with consistent association of goitre 
with deaf mutism. Pendred’s syndrome is generally limited to single 
generation. 
4.  Coupling defect – Failure to couple iodotyrosines uncommon – 6 
cases reported, more common in females. 
5.  Iodotyrosine deiodinase defect - uncommon. 
6.  Abnormal serum iodinated polypeptides – rare. 
Childhood Goitre 
 The presence of nodule or nodules in the thyroid gland in a child 
raises the strong possibility of malignancy, more likely to be malignant in 
a child than in an adult. Likelihood of malignancy increases when the 
nodule is single, hard and does not concentrate radioiodine (cold nodule). 
It has been examined at Mayo clinic from 1908 to 1955, that, of 130 
children with nodular enlargement, 68 had adenoma, 46 had carcinoma, 8 
had lymphocytic thyroiditis, 5 had goitrous cretinism, and 3 had 
congenital goitre. Thus carcinoma accounted for 35.4% of patients with 
nodular goitre. The nature of the diseases that produce the nodular 
enlargement in a child cannot be determined in most instances, except by 
histology. Thyroid hormones are required for female reproductive 
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functions. Physiological variations in hormones during menstruation, 
pregnancy and lactation contribute to the development of goitre, more 
common in females than males. 
CLASSIFICATION OF THYROID NODULES 
 There is no universally accepted classification, as the aetiology of 
the nodular goitre is presumptuous and pathological appearances are 
often difficult to correlate with clinical features (Alan Newton, 1950). 
 Any classification must be workable and usable to clinician and 
pathologist and simple to avoid confusion, so admittable to change and 
revisions made by the newer concepts. (Warren and Meissner 1953). 
WHO CLASSIFICATION 
Stage Clinical findings 
0-A No goitre 
0-B Goitre detectable only by palpation and not visible even when the 
neck infull extended 
1 Goitre palpable, but visible only when the neck is fully extended 
2 Goitre visible with the neck in normal position 
3 Very large goitre which can be recognized at a considerable distance 
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CLASSIFICATION OF TYPES OF GOITRE IN INFANCY AND 
CHILDHOOD 
 I Thyroid enlargement resulting from compensating action of 
impaired hormonopoiesis. 
1. Familial iodine induced goitre secondary to metabolic inborn errors. 
• Iodine transport defect 
• Organification defect 
 Lack of iodine peroxidase 
 Lack of iodine transferase (Pendreds syndrome associated with 
congenital nerve deafness). 
• Coupling defect 
 Iodothyrosine deiodinase defect. 
• Abnormal iodinated polypeptides 
 Resulting from defects in intrathyroidal proteolysis of 
thyroglobulin. 
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 Abnormal plasma binding, preventing use of thyroxine by 
peripheral cells. 
2. Endemic goitre resulting from iodine deficiency. 
3. Goitre due to drugs or naturally occurring goitrogens 
• Inhibitors of hormone synthesis27 
 Thiourea Thiouracil Propyl thiouracil Methymazole 
 Sulphonamides Para aminosalicylates Phenyl butazone  
Methylxanthine 
• Inhibitors of iodine accumulation 
 Perchlorates Thiocynates  Nitrates 
• Natural goitrogens 
 Cabbages  Turnips  Soyabeans 
• Miscellaneous 
 Cobalt Resorcinal Dihyroquinine 
II. Thyrotoxic goitre 
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• Neonatal 
• Childhood 
III. Goitre in Thyroiditis 
 Acute, Subacute (Dequervains), Chronic thyroiditis ,Riedel’s thyroiditis 
IV. Nodular goitre 
• Cysts 
• Benign and malignant neoplasms 
PATHOGENESIS OF THYROID NODULES 
 Thyroid nodules whether toxic, simple or malignant seem to arise 
as a result of thyroid follicles losing their dependence of thyroid 
stimulating hormone, a breakdown suggested that the nodules in the 
nontoxic goitre are initially little foci of hyperthyroidism. He traced the 
origin of thyroid nodules back to the stage of simple hyperplasia. It is at 
this stage that the goitre is preventable. 
AUTO RADIOGRAPHIC STUDIES 
 This method of study consists of a slice of the thyroid gland 
exposed to a photographic film, which becomes black when the tissue 
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contains radioactive material. Thus it makes possible for comparison of 
any area of thyroid with its capacity to concentrate and bind iodine to 
protein, in other words to synthesize thyroid hormones. By this study the 
evolution of the nodular goitre is divided into five stages (Selwyn Taylor 
Hypothesis). 
Stage I: The diffuse enlargement of thyroid gland, which shows 
increased vascularity, a large uptake of radioiodine and with uniform 
blackening of auto radiograph. This is typical of puberty goitre but many 
persist for years. 
Stage 2: Discrete focal areas of hyperplasia with corresponding 
blackening of autoradiograph. There are very few patients in whom all 
the functioning thyroid tissue is concentrated in a single area. Rawson 
described this very aptly as a toxic nodule in a nontoxic gland. Patient 
presents with erythroid state in this stage. 
Stage 3: Lobules become increasingly hyperplastic and vascular. 
 This stage is typified by disruption and haemorrhage. The blood 
supply in the nodules is carried by this walled tortuous dilated vessels, 
which bleed easily producing haemorrhagic necrosis by compression of 
surrounding tissue, fibrous pseudo capsule is formed around part of the 
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nodule with obliteration of small vessel and formation of Arteriovenous 
shunt. These perinodular shunts also adversely affect blood supply of 
nodule. Therefore, bleeding and necrosis in the nodule is common. 
Stage 4: Nodules undergo resolution in one or two ways, either a large, 
lace of colloid fills it and this is found to be free of iodine or mass of new 
follicles grow to supercede it and again their colloid does not take up 
radioiodine. 
Stage 5: The Multinodular goitre is brought about by continued repetition 
of the process described above, with the result that most of nodules are 
inactive and incapable to metabolize iodine but among them are few 
active foci, which are currently supplying normal body requirement. In 
the hypothesis of Selwyn Taylor, the functioning nodule was a stage in 
the evolution of all nodular goitre is questioned by Scintiscan studies to 
determine the function of solitary or dominant thyroid nodule. It has been 
demonstrated in autonomous micro or macro nodules in the same thyroid 
gland suggesting that small nodules function in this manner form their 
origin. Auto radiographic studies with gross autonomous functioning 
nodule have demonstrated similar functioning micronodules. 
 Transition from functioning to non-functioning nodule may occur 
through degenerative change or possibly by simple loss of functional 
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capacity of follicles. Autonomous micronodules from the very early stage 
suggest partial loss of trophic control. The finding of functioning 
micronodule in the same gland with similar macro nodules strongly 
suggests that large nodules were functioning through the period of 
growth. High levels of monoiodotyrosine and diiodotyrosine are found in 
cold nodules and low in hot nodules. 
HISTOPATHOLOGY OF MULTINODULAR GOITRE 14, 15 
 The initial stage of nodular goitre is a simple goitre. With the 
passage of time due to repeated involution and hyperplasia, multiple 
nodules appear gradually. These nodules increase with advancing years. 
The thyroid acini are divided into three types depending upon the stage. 
Resting stage: The acini are large, lined by flattened cells and filled with 
dense homogenous colloid. 
Secretory Stage: Acini are lined by cuboidal epithelium and their colloid 
does not stain intensely. 
Response Phase: Acini are lined by columnar cells and contain highly 
stained vacuolated colloid. As the simple goitre changes to nodular goitre 
the histological appearance vary according to the stage. 
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I. Stage of hyperplasia 
 It is due to increased TSH, which is secreted in response to low 
levels of circulating thyroid hormones. 
HISTOLOGY 
 Here the acini are hyperplastic and distorted by ingrowths and 
invagination of epithelium. The acini are lined by tall columnar cells. The 
colloid is less in amount. This phase will slowly change into colloid 
goitre. 
II. Colloid Phase 
 It cannot be differentiated from hyperplastic gland clinically. 
Histology 
 Here the gland is a mixture of hyperplasia with colloid acini. The 
acini are lined by cuboidal cells. The concentration of iodine is less than 
normal gland. When the supply of iodine increases, the gland undergoes 
involution. Both hyperplastic and colloid goitre are associated with 
euthyroidism. 
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III. Nodular Phase 
 It is an irreversible stage of a simple goitre and is due to repeated 
stimulation of the gland. The process of hypertrophy, hyperplasia and 
involution follow repeatedly. Faulty areas of involution associated with 
colloid distension will compress the normal glandular tissue. This with 
newly formed fibrous tissue causes the nodule to become encapsulated. 
Macroscopically the nodules may be single or multiple. The nodules may 
be pale yellow pink and opaque in appearance. Dissolution of follicle lead 
to cyst formation and cyst may contain cholesterol crystals and colloid 
material. 
Histology 
 Microscopically nodular goitre appears as colloid goitre. It consists 
of poorly defined fibrous capsule containing colloid filled acini, which 
are lined by low cuboidal epithelial cells. 
Retrosternal goitre 
 Most retrosternal goitres arise from lower pole of a nodular goitre. 
Very few retrosternal goitre arise from ectopic thyroid tissue. If the neck 
is short and pretracheal muscles are strong in men, negative intrathoracic 
pressure tends to draw these nodules into superior mediastinum. A 
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retrosternal goitre is often symptomless and is discovered on a routine 
chest radiograph. It receives its blood supply from inferior thyroid 
vessels. Retrosternal goitre may be 
1.  Substernal – commonest type, lower border of thyroid is behind 
the sternum. 
2.  Intrathoracic – No thyroid is seen in the neck. Diagnosis is by 
radioiodine scan. 
3.  Plunging type – when intrathoracic pressure raises as when the 
patient coughs, lower border is seen in the neck. 
 A retrosternal goitre however can cause severe symptoms. 
• Dyspnoea – particularly at night with cough and stridor, due to           
pressure on trachea. 
• Dysphagia – due to pressure on oesophagus. 
• Pressure on great veins at thoracic inlet gives rise to enlargement of 
  veins on neck and front of chest. 
•  In severe cases there may be obstruction of superior venacava. 
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  A retrosternal goitre may be toxic or malignant. A chest radiograph 
in case of retrosternal goitre shows widened soft tissue shadow in 
superior mediastinum sometimes with calcification and often causing 
deviation and compression of trachea. 
COMPLICATIONS OF MNG 
The complications of MNG are as follows: 
1. Secondary thyrotoxicosis 
 Its incidence is difficult to estimate but figures as high as 30% are 
reported.16 In most cases of toxic nodular goitre the nodules are inactive 
and  the internodular tissue is over active which is due to a family of IGG 
immunoglobulins which bind with TSH receptor sites (TRABS) and 
activates TSH receptors on follicular cell membrane. They have a more 
protracted action than TSH (16-24 hours versus 1.5 to 3 hours). However 
in few cases one or more nodules are overactive.  
2. Tracheal compression 
 It may be due to gross displacement of trachea in lateral or 
anteroposterior plane. It is commonly due to haemorrhage into a nodule 
and in retrosternal goitre. 
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3. Malignant change 
 It is one of the most controversial subjects which is still not settled. 
It is an uncommon complication. The incidence of carcinoma in MNG 
has been reported as 5-10%.3 In this view Sokal has reported that 4% to 
17% of nodular goitre develop thyroid cancer 18, 19. The malignancy is 
usually of follicular type. 
APPROACH TO MULTINODULAR GOITRE 20, 21 
 The thyroid nodule may be palpable or hidden and symptomatic or 
asymptomatic. The thyroid nodules of less than 1-2 cms are not palpable. 
The gland may be normal or abnormal in structure and function. 
CASE HISTORY 
 The symptoms are important evidence to know whether hyper or 
hypo thyroidism is associated with goitre. The patient and family 
members may have noticed alteration in mental activity irritability or 
excitability. The patient may give history regarding alteration in 
temperature tolerance, perspiration and change in weight, bowel habits 
and appetite or eye changes or palpitation. Pressure symptoms like 
dysphagia, hoarseness of voice, or dyspnoea may occur with goitre. A 
history regarding diet, ingestion or goitrogenic foods like cabbage, 
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soyabeans and drugs should be elicited. History of having stayed in 
endemic area and family history of similar swelling should be recorded. 
GENERAL PHYSICAL EXAMINATION 
 Here the signs of hyper or hypothyroidism are to be recorded. 
Tachycardia during sleep and loss of weight in hyperthyroidism, whereas 
bradycardia and weight gain are seen in hypothyroidism. The extremities 
will be hot and moist in hyperthyroidism and cold and dry in 
hypothyroidism. Tremors of hand and tongue are seen in 
hyperthyroidism. Eye signs are characteristic of primary thyrotoxicosis 
and these include Stelwag’s sign, Van Graef’s sign, Joffroy’s sign and 
Moebius sign. In secondary thyrotoxicosis the eye signs are not the 
characteristic feature.22 
LOCAL EXAMINATION 
Inspection 
 It is the most important part of examination. It provides lot of 
information and thyroid gland is confirmed by movement with deglution. 
To know the retrosternal extension of the goitre, one must look for the 
lower border of the gland. 
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Palpation 
 The gland is palpated both from behind and in front of the patient, 
for better palpation of localized nodules. During palpation consistency 
and type of enlargement of the gland is noted. The surface is bosselated 
with gross varying of consistency in MNG, where as in thyroid carcinoma 
the consistency is hard, with indistinct margin and irregular surface. If 
lower border of the gland is not felt, it suggests retrosternal goitre. 
Examination of regional lymph nodes, carotid pulsation and position of 
trachea must be done routinely. For simple nodular goitre thyroid 
function tests are not required as normal thyroid function is maintained. 
Stippled calcifications may be noted on x-ray of the neck in MNG. Now-
a-days FNAC has changed the management of MNG and has helped to 
plan for surgery in advance, but has 5% to 30% of both false positive and 
false negative results. Iodine131 scan differentiates thyroid nodules into 
cold, warm and hot nodules. 
INVESTIGATIONS FOR MNG 
Diagnostic tests of thyroid function and structure 
 Now-a-days varieties of tests that provide objective evidence of the 
status of thyroid function and to assess the thyroid lesions are increasing 
constantly. No single test or procedure consistently yields a reliable result 
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for diagnosis, but each test has a specific indication. Most frequently the 
results of tests combine to provide a correct overall assessment of thyroid 
function and structure. 
I. Tests for thyroid function 
1.  Thyroid hormones (T4 and T3) assay 
2.  Tests of thyroid binding proteins 
3.  Free thyroid hormone indices 
4.  Free thyroid hormone measurements (FT4 and FT3). 
5.  Pituitary thyroid axis (TSH) assay 
6.  Hypothalamic – pituitary axis (TRH test) 
II. Imaging studies of the Thyroid 
1. Radionuclitide Imaging 
  I123 
  I131 
  Tc99m pertechnetate 
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III. Assessment of thyroid anatomy 
• Ultrasound scan 
• Computerised tomography (CT) 
• Nuclear magnetic resonance imaging (NMRI). 
IV. Tissue diagnosis 
• FNAC 
V. Measurement of thyroid autoimmunity 
• Anti-thyroglobulin antibodies 
• Antimicrosomal antibodies 
• Long acting thyroid stimulator (LATS) 
• Thyroid stimulating immunoglobulins (TSI) 
VI. Miscellaneous tests 
• X-ray of the neck – AP and lateral vews,  X-ray of the chest - PA view 
• Indirect laryngoscopy, Thyroglobulin assay, Calcitonin assay 
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ULTRASOUND SCAN 
 Ultrasonography has occupied a definite place in the management 
of diseases affecting various parts of the body, ever since its introduction 
to the medical field. Its part in diagnostic approach of thyroid diseases 
has not been well defined, but it represents the first modality that has 
made it possible to establish the physical state of thyroid lesion before 
surgery. The thyroid nodularity evaluation with normal or enlarged 
volume can be performed with a much higher sensitivity by high-
resolution ultrasonography when compared with palpation. Alderson, 
summer and Seigal reported that approximately 36% of clinically 
diagnosed solitary nodules were multiple on scan. By ultrasound, solid 
cystic and mixed solid cystic nodules can be differentiated. Among the 
solid nodules, those of high or normal echogenicity can be distinguished 
from those with reduced echogenicity by comparison with normal thyroid 
and the neighbouring muscular tissue. This may be helpful in determining 
the nodules to be investigated further by FNAC to exclude or confirm 
malignancy, but it has to be emphasized that the sonomorphological 
appearance of a nodule per se does not exclude malignancy. Ultrasound 
also cannot differentiate between functioning and non-functioning 
nodules. 
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FINE NEEDLE ASPIRATION CYTOLOGY (FNAC) 
 For the last 15-20 years, there is a remarkable change in the 
approach to diagnose thyroid nodules. FNAC involves establishing a 
tissue diagnosis by needle aspiration cytology. FNAC has occupied a 
definite place in the investigation and management of thyroid nodules. 
The most common approach is to use a smaller needle (Gauge 23-25) and 
G 10-20 ml syringe. This technique provides material for cytological 
rather than histological interpretation. 
PROCEDURE 
 The patient is put in supine position with a pillow under the 
shoulder to push the thyroid nodule more anteriorly. The nodule is 
mobilized between the fingers and thumb of one hand and the needle is 
inserted using firm pressure with the other hand, to help stabilize the 
syringe and the needle. Now suction is obtained in the syringe to create a 
negative pressure. Then the needle is moved back and forth in the nodule 
in different directions, with the negative pressure maintained. As soon as 
the material is seen in the barrel of the syringe, pressure is released to re-
establish atmospheric pressure in the syringe. The syringe is disconnected 
with the needle still in situ. The syringe is filled with air and reattached to 
the needle and then removed with the needle. Now, the tissue drop is 
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gently expressed on to a glass slide. One half of the slide is placed as 
quickly as possible in 95% alcohol (fixative), the remainder is dried in 
air. The immersed part is stained using Papanicolou or an equivalent 
stain, the air dried part with Wright’s stain, which demonstrates colloid. 
There are four broad categories into which the results fall, malignant, 
benign, suspicious and inadequate. In the last case, the aspirate should be 
repeated. Papillary carcinoma, medullary carcinoma, anaplastic 
carcinoma and thyroiditis can be diagnosed with confidence using FNAC. 
Follicular adenoma cannot be differentiated form follicular carcinoma on 
cytological features alone, since identification of capsular and vascular 
invasion is important for diagnosis of follicular carcinoma. Ashcraft and 
Van Herle in an extensive review of the literature found that the overall 
accuracy of the procedure has around 90%, false positive rate around 3-
8% and false negative rate around 5%. When FNAC report comes as 
follicular adenoma or suspicious of malignancy, surgery has to be 
undertaken to confirm the pathology. 
 M. A. Tabaqchali et al 23, in a study conducted in U.K. concluded 
that FNAC is invaluable and minimally invasive procedure, for the 
preoperative assessment of patients with a dominant thyroid nodule. 
FNAC predicted neoplasia with a sensitivity of 86.8%, a specificity of 
67.0%, negative predictive value of 87.5% and a positive predictive value 
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of 65.5%, malignancy was predicted by FNAC with a sensitivity of 
88.9%. M. Serralva 24 et al in a study in Portugal concluded that FNAC is 
a reliable thyroid lesions diagnostic method with an elevated accuracy, 
sensitivity and specificity. However one of its limitations is its inability to 
differentiate between benign follicular tumour from the malignant. 
CYTOLOGICAL AND HISTOLOGICAL FEATURES OF 
DIFFERENT THYROID DISORDERS 15 
1. Normal thyroid: 
 Small clusters and sheets of epithelial cells with small amount of 
thin colloid, C cells, cartilage, tracheal epithelium and skeletal muscle 
may be found. 
2. Nodular colloid goitre: 
Diagnostic criteria are as follows 
•  Abundant colloid of both thick and thin types 
•  Follicular cells in sheets and clumps, fragile feathery cytoplasm, 
• numerous bare nuclei 
•  Foamy cells 
•  Degenerating erythrocytes 
•  Hyalinized stroma 
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3. Grave’s disease: (Primary Thyrotoxicosis) 
• Blood stained smear with little colloid 
•  Moderate amount of epithelium and some follicular and ring    
structures 
•  Enlarged cells with more abundant vacuolated cytoplasm, 
variation in nuclear size 
•  Fire flares/ colloid suds/ marginal vacuoles are the features in this 
disorder 
4. Hashimoto’s thyroiditis: 
•  Presence of Ashkenazy cells 
•  Moderate number of lymphocytes mainly of small mature type and 
scattered plasma cells 
•  Small multinucleate giant cells, epitheloid histiocytes 
•  Thyroid follicles disrupted and the follicular basement membrane 
is damaged with enlarged epithelial cells with characteristic 
oxyphilic change in the cytoplasm 
5. Mulitnodular goiter: 
 Microscopically there will be normal to hyperplastic foci of thyroid 
tissue, large areas of colloid, haemorrhage, fibrosis and calcification, 
variable amounts of lymphocytic infiltration can also be seen. 
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6. Follicular adenoma: 
 These are 3 types, according to their architecture, cellularity and 
amount of colloid. They are fetal colloid, embyonal and Hurthle cell 
types. Hurthle cell lesions contain cells that are markedly eosinophilic 
and whose cytoplasm contains abundant mitochondria. 
7. Follicular carcinoma: 
 These may be non-invasive (minimally invasive) or invasive (angio 
and capsular invasion). In few cases Hurthle cells are present which show 
aggressiveness of the tumour. 
8. Papillary carcinoma: 
 Presence of colloid filled follicles with papillary projections. In 
some cases calcified lesions are found which are called Psamomma 
bodies, which is diagnostic feature of papillary carcinoma. In few cases, 
presence of orphan eyed nuclei Annei with a pale empty nuclei may be 
seen. 
9. Medullary carcinoma: 
 Dispersed cell pattern, cuboidal cells with oval, eccentric 
pleomorphic nuclei and well defined gray blue cytoplasm, spindle cell 
forms with elongated cytoplasm, red cytoplasmic granularity and 
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presence of amyloid material in the background are the characteristic 
features. 
10. Anaplastic carcinoma: 
 Bizarre, large malignant cells with macrophage like appearance, 
multinucleate malignant cells, and malignant spindled cells with 
mesenchymal appearance and necrotic cell fragment debris with a dirty 
background are the features. 
11. Lymphomas: 
 Shows mixed cell population resembling reactive processes like 
elsewhere in the body. 
HISTOLOGICAL FEATURES OF DIFFERENT THYROID 
DISEASES: 
 
SLIDE 1: COLLOID GOITRE 
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 SLIDE 2: HASHIMOTOS THYROIDITIS  
 
SLIDE 3: FOLLICULAR  ADENOMA 
 
SLIDE 4:FOLLICULAR CARCINOMA 
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SLIDE 5: PAPILLARY  CARCINOMA 
 
SLIDE 6:ANAPLASTIC  CARCINOMA 
 
 
SLIDE 7:MEDULLARY  CARCINOMA 
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RADIOIODINE UPTAKE AND THYROID SCAN 
 In 1951, Cassen and his co-workers were among the first to use 
automatic radioisotope scanning for diagnosis of diseases in body organ. 
They selected thyroid gland naturally as the first organ for studying. The 
remarkable avidity of the thyroid gland for radioiodine permitted 
visualization even with the primitive scanning equipment available at that 
time. 
RADIOIODINE UPTAKE 
 This is tested by giving a known amount of radioactive iodine to 
the patient and measuring the percentage taken by the thyroid by an 
external counting device. Radionuclide iodine used are I123 and I131. The 
radionuclide is given by mouth either in capsule form or as liquid from 
and the measurement is made at a known time after ingestion. The 24 
hour uptake is most useful;  
 
 The uptake measurement depends on the function of the thyroid 
gland and the size of the iodine pool or more precisely the plasma 
inorganic iodine. Originally the test was used in differentiating normal 
people from hyperthyroid and hypothyroid patients. But it was 
subsequently found that there are many conditions associated with low 
uptake of radioiodine and the patient can be clinically hyperthyroid, 
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euthyroid or hypothyroid. Also high uptake can be due to many causes 
apart from hyper thyroidism. Hence, uptake measurement cannot be used 
to determine thyroid functional states. It has to be defined clinically and 
by measurement of thyroid hormone preferably FT4, FT3 and TSH. 
Causes of increased radio iodine uptake 
1.  Hyperthyroidism  Graves disease, Toxic adenoma, Toxic MNG 
2.  Iodine deficiency 
3.  Recovery form thyroiditis 
4.  Dysharmonogenesis except trapping defect 
5.  After stopping anti-thyroid drugs 
6.  in neonates 
Causes of decreased radioiodine uptake 
1.  Iodine load  Dietary, Radiographic contrast agents,Medicines with 
 inorganic iodine 
2.  Thyroxine or other thyroid medication – factitious thyroiditis 
3.  Hypothyroidism 
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4.  Ectopic thyroid 
5.  Radio nuclide capsules not ingested or digested 
6.  after severe exercise  
7.  Technical error. 
The two main indications for the tests are 
1.  To differentiate those patients with hyperthyroidism and high 
uptake from those with low uptake 
2.  The test is a prerequisite to treating a patient with radioiodine. 
 It is important to ensure before making an uptake measurement that 
the patient is not taking any thyroid or antithyroid medications, and not 
been on any recent radiographic contrast injections or intake of iodine 
containing medicines. Thyroxine has to be stopped 4 weeks before and 
T3 for 2 weeks before doing the test. TC99m as per technate can be used 
for uptake measurement. It is normally used in a range of 0.2% to 3.0%. 
It is highly useful in situations where it is essential to establish the 
diagnosis of hyperthyroidism urgently. Technetium uptake can confirm 
this within minutes. The main clinical problem with its use could be 
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severe toxicity, fever, tachycardia confusion and obtundation in a patient 
with goitre. 
THYROID SCINTIGRAPHY 
a) Routine Scintigraphy 
 Thyroid Scintigraphy as volume test became possible with the 
development of the rectilinear scanner by Casson. Now imaging is done 
by using  camera with a pinhole collimator. The radionuclide I123 is given 
by mouth as a capsule and scintigrams are obtained 3-6 hours later. Now 
a days Technetium 99m (TC99m) which is normally taken up by thyroid, 
like iodine, is used. 
The usefulness of scan has been for: 
1.  Determining the size of the gland 
2.  Determining if a nodule concentrates the radioiodine or (TC99m) 
or not i.e, hot or cold or warm (normal). The risk of malignancy in 
cold nodule is around 20%, Hot or warm nodule (<5%) 
3.  Determining if a retrosternal shadow on chest radiograph is due to 
thyroid. 
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4.  Determining if a lump in the tongue or track of thyroglossal duct 
containing functioning thyroid and ectopic thyroid. 
5.  For evaluation of toxic MNG 
 Normally more thyroid scans are obtained to determine whether the 
nodule is hot or cold than for any other reason. This is because 
malignancy is extremely rare in MNG and thyroid cancers are often cold 
on scan. The principle value of isotope scanning is in a toxic patient, with 
a nodule or nodularity of thyroid. Localization of over activity in the 
gland will differentiate between toxic nodule with suppression of 
remainder of gland and toxic Multinodular goitre with several areas of 
increased uptake with important implications for therapy. Routine isotope 
scanning in thyroid swelling is unnecessary.  
b)  Whole body Scintigraphy for thyroid metastases 
 Whole body Scintigraphy is designed to provide information about 
the pressure or absence of functioning metastases from differentiated 
thyroid cancer. The test is of no value in anaplastic or medullary cancer. 
It should be done only after total thyroidectomy because if it is done in 
the presence of significant amount of normal thyroid tissue, the radio 
iodine localizes preferentially in that site and metastases are not 
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visualized. Autoradiographic studies have shown that metastatic thyroid 
cancer have about 1% of the uptake of normal thyroid. Most nuclear 
physicians use 1 or 2 mci of I131, whole body Scintigram should be 
delayed for about 4 weeks from the time of surgery to allow 
endogenously secreted thyroid hormones to be metabolized and TSH to 
raise. Blood is drawn for TSH and thyroglobulin before the dose of 131I 
is administered. A whole body scan is obtained 48-72 hours after the 
radioiodine dose is administered. This delay allows background activity 
to fall to very low level, and it allows sufficient time for metastases to 
trap iodine. An anterior and a posterior whole body images as well as pin 
hole images of the thyroid are obtained. Functioning metastases take up 
radio iodine and appear on the scan. Normal uptake is expected in 
residual salivary gland, stomach, colon and bladder. The main drawback 
of this scan is that about 10% of differentiated thyroid cancers do not 
concentrate radioiodine. 
 Sometimes false positive results occur. Eg. Bronchitis and 
bronchiectasis cause positive uptake in lungs. Uptake in the lesions can 
be calculated so that the dose of radioiodine required to ablate the 
metastases can be made. 
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MISCELLANEOUS RADIOLOGICAL STUDIES 
Computerized Tomography (CT) 
 There is no place for a CT scanning in routine evaluation of 
patients with thyroid disease. The following are the indications for CT. 
1.  Substernal goitre not concentrating iodine. 
2.  Thyroid malignancy to rule out infiltration to adjacent structures. 
HORMONAL ASSAY 
TOTAL THYROID HORMONES 
 Total T4 and T3 are measured by specific radioimmunoassay. 
Since they are highly protein bound, their values depends on the levels of 
the binding proteins in the serum. Most patients with hyperthyroidism 
with normal levels of protein have high T4 and T3 less commonly only 
T3 is high (T3 toxicosis) and this is more characteristic of 
hyperthyroidism due to a functioning autonomous nodule, early Grave’s 
disease or those replacing after stopping anti-thyroid drugs. The normal 
total plasma T4 level is approximately 8 micro g/dl and plasma total T3 
level is 0.15micro g/dl.12 
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CAUSES OF HIGH LEVEL OF THYROID HORMONES 
• Hyperthyroidism 
• Increased binding proteins 
 Pregnancy Oral contraceptive Active hepatitis Hereditary 
 Porphyria  New born 
• Acute psychiatric illness 
• Acute medical illness 
• Antibody to thyroid hormones 
• Pituitary resistance to thyroid hormones 
CAUSES OF LOW LEVELS OF THYROID HORMONES 
(TOTAL) 
• Hypothyroidism 
• Decreased binding proteins 
 Androgens  Nephrotic syndrome  Hereditary  Glucocorticoids 
 Cirrhosis of liver  Non thyroidal illness  Low T3 syndrome 
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 Low T3 and low T4 (sick euthyroid) 
TESTS OF THYROXINE BINDING PROTEINS 
 For estimation of TBG and TBPA there are specific 
radioimmunoassay tests. Because TBG is the most important protein, 
carrying 70-80% of the hormone, it is usually measured alone. Thyroxine 
binding capacity (TBC) can be measured indirectly by quantitating the 
capacity of binding sites in serum, which are not carrying hormone. This 
is done using the T3 resin uptake test (T3RU) and usually it is in the range 
of 25% to 35%. If there are a lot of unoccupied binding sites on the 
proteins, the racer will bind there and the T3RU is low and vice versa. 
Knowledge of T4, T3 and T3RU values makes it possible to determine if 
the problem is due to thyroid diseases, or to a binding protein 
abnormality. If both the tests are abnormal in the same direction, the 
thyroid is at fault, Eg. If T4 and T3RU are both high, hyperthyroidism is 
diagnosed. In contrast if one test is high and the other low, the defect is 
due to carrier proteins. 
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FREE THYROID HORMONE INDICES (BY CALCULATION) 
This is obtained by the formula: 
FT4 I= (Total T4) (T3RU) 100 
FT3 I= (Total T3) (T3RU) 100 
 These tests have gained widespread acceptance in practice because 
the two tests used for its derivation are simple and are robust. 
 Free thyroid hormone (FT4) measurement FT4 can be measured by 
two methods, Equilibrium dialysis or radioimmunoassay. It is generally 
accepted that the dialysis method is the gold standard, however it is 
restricted to research laboratories. Radioimmunoassay is sensitive and 
specific. FT4 measurement provides excellent index of thyroid status in 
almost any clinical situation with the few exceptions, which are very rare. 
E.g. Heparinized patients and in acute psychiatric illness. This test is not 
influenced by abnormalities in the thyroid binding proteins. 
Pituitary Thyroid axis – TSH 
 TSH radioimmunoassay became available in 1965. When TSH is 
above normal and T4 and T3 are normal, it is called subclinical 
hypothyroidism. But older assay could only differentiate TSH levels of 1 
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μu/ml or 2 μu/ml and since many euthyroid individuals have TSH levels 
of 0.5μu/ml to 2.0 μu/ml, assay could not separate suppressed values 
from normal values, but with the introduction of immunoradiometric 
assay (IRMA) and amplified enzyme linked immunoassay (AEIA), TSH 
levels less than 0.3 micro units/ml can be detected. TSH is an extremely 
valuable diagnostic aid, hypothyroid patients have high levels and 
hyperthyroids have low levels, provided pituitary insufficiency is 
excluded. When thyroid hormones are at normal level and TSH in 
undetectable it is called subclinical hyperthyroidism. Hypothalamic 
pituitary axis (TRH Test) 
 Thyrotrophin releasing hormones was isolated characterized and 
synthesized in 1968 and soon became available for clinical use. This is 
tested by injecting TRH intravenously and evaluating the response of the 
pituitary to secrete TSH. A normal response is a rise in TSH, which is 
maximal at 20-30 minutes with return to normal by 60-90 minutes. In 
hyperthyroidism the pituitary is suppressed by thyroid hormone and there 
is no rise in TSH after injection of TRH. This test was of great value in 
understanding the physiology and pathophysiology of the hypothalamic 
pituitary thyroid interaction and it was valuable clinically in the diagnosis 
of borderline hyperthyroidism. Because of the development of sensitive 
TSH measurement, which shows suppressed levels in hyperthyroidism, 
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the TRH test is superfluous in this role. Patients with primary 
hypothyroidism have an elevated TSH by definition; therefore TRH test 
is also superfluous in this situation. 
MISCELLANEOUS INVESTIGATION 
• X-ray of neck –AP and lateral views to assess the position of trachea 
and to determine tracheal compression or displacement in anteroposterior 
or lateral plane, tracheal calcifications, tracheomalacia and scabbard 
trachea. 
• X-ray of chest – PA view to see for widened mediastinal shadow in 
case of retrosternal goitre. 
• Indirect laryngoscopy – To record asymptomatic recurrent   laryngeal 
paralysis being of medico legal importance. 
• Recording of sleeping pulse rate in the diagnosis of thyrotoxicosis and 
its severity is based on the pulse rate as follows: 
 Mild -- 90-100 beats/ minute 
 Moderate -- 100-110 beats/ minute 
 Severe -- >110 beats/ minute 
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TREATMENT OF MULTINODULAR GOITRE 
 When treatment of MNG is considered the patient’s overall health 
and comorbidities required critical assessment. The aetiology and  
co-existent thyroid diseases associated with MNG often direct the 
ultimate type of treatment. Toxic and nontoxic MNG should be addressed 
separately, and the type of treatment should be directed at each of these 
types of MNG, as well as the issues related to the success of each 
treatment option. Treatments include non-surgical and surgical 
approaches. Regional trends often influence the management of MNG. In 
general, surgery is necessary in extremely large MNG for cosmetic 
appearance, suspicion of malignancy, tracheal or esophageal 
symptomatology, substernal extension, vocal cord paralysis and rapid 
growth otherwise consideration should be given to medical or radioiodine 
treatment. Development of goitre is usually due to iodine deficiency, 
which causes the gland to hypertrophy due to TSH stimulation, so 
measures to prevent iodine deficiency are taken. 
PROPHYLAXIS 
 Endemic goitre is one where 10% or more population living in an 
area shows signs of thyroid enlargement. Iodine is used as a preventive 
measure in endemic region. This is achieved by iodinating the table salt. 
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The concentration used is potassium iodide 1 part in 10,000. In most of 
endemic areas like Switzerland, Argentina, parts of USA, the incidence of 
endemic goitre is decreasing due to iodination of the table salt. 
PLAN OF ACTION IN INDIA 25 
 The Government of India launched a National Goitre Control 
Programme. 
 The objectives of the programme are as follows: 
a)  Survey of goitre suspected area to identify goitre endemic region. 
b)  Production and supply of iodinated table salt to endemic area. 
c)  Resurvey after 5 years of continuous supply of iodinated salt in 
endemic area to assess the impact of control programme. 
 The UNICEF has donated iodinated plants; they are working at 
Howrah, Hharghoda, Sambhar lake and Gauhati. Their main aim is 
production and supply of iodinated salt to all endemic areas Intramuscular 
injection of iodized oil is used in preventing endemic goitre in areas 
where iodized salt cannot be consumed. Iodized poppy oil in a dose of 1-
2 ml for adults and smaller doses for infants and children and repeated 
once in every 3 years. 
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FACTS FOR ROUTINE REMOVAL OF MNG (SOKAL) 19 
a.  Statistics from various centres throughout the world indicate that 
4%-17% of nontoxic goitres are malignant. 
b.  Nodular goitre, is usually benign but is likely to become malignant 
later, and therefore should be removed as a cancer prophylaxis. 
 No author recommends prophylactic thyroidectomy but some 
mention thyroidectomy in nodular goitre on the basis that nodules are 
likely to be malignant than becoming malignant. 
1. Surgery for simple MNG 
 Nodular stage of simple goitre is irreversible. Most patients of 
MNG are asymptomatic and do not require operation. Operation may be 
indicated on cosmetic grounds, if the goitre is unsightly. Retrosternal 
goitre with actual or incipient tracheal obstruction is an indication of 
operation, as in   the presence of a dominant area of enlargement, which 
may be neoplastic.  
There is a choice of surgical treatment: 
 Total thyroidectomy with immediate and lifelong replacement of 
 thyroxine. 
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2. Surgery for toxic MNG 28 
 Patients with toxic multinodular goitre should be treated with anti 
thyroid drugs to bring the patient to euthyroid state before surgery. The 
curative treatment for toxic MNG is total thyroidectomy. 
3. Treatment of retrosternal goitre (RSG) 
 Resection of retrosternal goitre can almost always be performed 
from the neck and a midline sternotomy is hardly even necessary. The 
cervical part of the goitre should first be mobilized by ligation and 
division of the superior thyroid vessels and ligation and division of 
middle thyroid veins and inferior thyroid vessel. RSG can then be 
delivered by traction and finger mobilization. Bleeding is rarely a 
problem because the goitre takes its blood supply with it from the neck. 
Prof. M. H. Wheeler 29 of Cardiff, UK has suggested that most RSGs can 
be resected through an entirely cervical approach with a low complication 
rate. Sternotomy is required for large intrathoracic goitre where the 
thoracic inlet may be too small for delivery of the gland, for tumour with 
significant invasion and when uncontrolled bleeding is encountered. The 
rare truly ectopic intrathoracic gland with its major blood supply derived 
from intrathoracic vessels also dictates sternotomy. Sonal Pandya 30 
Laura, Esemders, Burlington, Massachusettes describe a method where 
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by a Foley catheter placed beyond the substernal component of goitre 
with steady traction on inflated balloon has been successfully and safely 
used in two patients and suggests that this may obviate the need for 
sternotomy. In the nontoxic MNG, surgery is performed mainly to 
prevent pressure effect for cosmetic purpose and whenever there is 
suspicion of malignancy. Although prophylactic surgery to prevent the 
occurrence of carcinoma is not justified in Multinodular goitre, 4% to 
17% of glands removed contain malignant foci. Surgery done is mainly 
subtotal thyroidectomy. 
 In toxic Multinodular goitre, surgery is the choice of treatment. 
Treatment with radioiodine is highly unreliable because blood flow 
through such goitre is not homogenous or as symmetrical as diffuse 
goitre. So the uptake of radioiodine by the goitre is irregular and many 
areas escape effective radiation and the hyperthyroidism continues. For 
this reason surgery is the treatment of choice for hyperthyroidism due to 
Multinodular goitre. 
 After subtotal resection it has been customary to give thyroxine to 
suppress TSH secretion with the aim of preventing recurrence. Whether 
this is necessary or effective is uncertain, although the evidence of benefit 
in endemic areas is better than elsewhere. 
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PREPARATION OF PATIENT PRIOR OF SURGERY 31, 16, 27 
 Patients with various thyroid disorders must be brought to 
euthyroid state before surgery. Untreated hyperthyroidism may lead to 
tachycardia and thyroid storm. Uncontrolled hypothyroidism may result 
in hypotension and respiratory distress. Carbimazole is the most 
commonly used drug in the treatment of hyperthyroidism. Carbimazole 
30-40 mg per day in 3-4 equally divided doses is given. Clinical 
improvement is apparent only with a latency of 7- 14 days. The drug dose 
is given at 6 or 8 hours interval, maintaining high concentration of the 
drug throughout 24 hrs. When the patient attains euthyroid state, the dose 
may be reduced to 5 mg 8 hourly and the addition of thyroxine may 
facilitate maintenance of the euthyroid state. The final dose of carbimzole 
is given on the night before surgery. The untoward reaction of 
neomercazole is agranulocytosis. The incidence of agranulocytosis is 
about 7% and usually occurs during the first few weeks of therapy but 
may occur later. Agranulocytosis is reversible on discontinuation of the 
drug. Preparation is as an outpatient and only rarely admission to hospital 
is necessary. A safer preparation is to control the clinical manifestations 
of the toxic state. Drugs used are Propranolol 40 mg thrice daily or 
preferably the longer acting Nadolol 160 mg once daily. Clinical response 
is rapid in beta–blockers .Beta-blockers donot act on the gland itself. 
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Propranolol inhibits the peripheral conversion of T4 to T3. They do not 
affect the thyroid hormone synthesis, so during treatment hormones level 
remain high and for some days after thyroidectomy. So the drugs have to 
be continued for 7 days postoperatively.  Lugols iodine, 5 drops three 
times daily in milk is claimed to reduce the vascularity of the goitre and 
make it firmer and easier to handle. Potassium iodide tablets 60 mg three 
times daily may be used as an alternative. 
TECHNIQUE 
TOTAL THYROIDECTOMY 32 
 A slightly curved transverse skin crease incision is made 2–3 cm 
above the sternum (it should not be positioned lower than this or the 
central portion of the scar will hypertrophy). The skin can be marked 
preoperatively using natural skin crease lines as a guide. Platysma is 
incised in line with the skin, and the skin and platysma flaps are elevated 
down to the sternum, and up to the thyroid cartilage. A self-retaining 
Joll’s retractor is then positioned to retract the flaps. The deep cervical 
fascia is incised vertically in the midline, and the strap muscles retracted 
laterally. If division of strap muscles is necessary they should be divided 
high up as their innervation is from below. They are repaired at the end of 
the procedure. The assistant retracts the strap muscles laterally, and away 
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from the surface of the gland. Areolar tissue around the gland is divided 
and the middle and inferior thyroid veins are displayed. These require 
ligation and division. The deepest of the inferior thyroid veins may be in 
close proximity to the recurrent laryngeal nerve, and the final ligations in 
this area may have to wait until the nerve has been identified. Attention is 
next turned to the superior pole. With gentle traction on the now partially 
mobilized lobe it should be possible to pass a rightangled forceps behind 
the superior pole vessels and pass a mounted tie around them. An 
aneurysm needle is also very useful for this step. The external laryngeal 
nerve is endangered during this manoeuvre, and it is important to try and 
find the window medial to the superior pole vessels and stay a few 
millimetres lateral to the surface of the larynx. The ligature is then tied as 
low as possible. A second ligature is tied above it, and an artery forceps is 
placed immediately above this second ligature. The vessels are then 
divided between the ligatures and a further ligature tied on the superior 
thyroid pedicle before the forceps is released. Too high a tie of these 
vessels also endangers the external laryngeal nerve. The lobe is then 
rotated medially out of its bed. The assistant is now retracting in a deeper 
plane, and the retractor is drawing the carotid sheath laterally. The 
inferior thyroid artery and the recurrent laryngeal nerve must now be 
displayed, and both lie beneath a fascial layer which must be incised. The 
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inferior thyroid artery is ligated in continuity, but only after the nerve is 
identified and safeguarded. An aneurysm needle is the easiest method of 
passing the tie beneath the artery, which is then ligated as lateral as 
possible to minimize any danger to the nerve. The final dissection of the 
deep portion of the gland off the recurrent nerve and the parathyroids is 
the most difficult, and must be performed with great precision. The 
medial surface of the lobe then separates easily from the trachea, and is 
finally only attached by the isthmus which is divided close to the 
contralateral lobe. A haemostatic continuous absorbable suture in the 
isthmus will control haemorrhage. Similarly other lobe is dissected. Total 
thyroidectomy done. A deep vacuum drain is placed beneath the strap 
muscles before they are approximated. The platysma is sutured, and 
finally the skin is closed using sutures or staples. 
POSTOPERATIVE COMPLICATIONS 
Haemorrhage 
 Due to slipping of the superior thyroid artery ligature, tension 
haematoma develops. Occasionally thyroid remnant or a thyroid vein may 
be responsible for haematoma. Sometimes it is necessary to open the 
wound to relieve tension, and the patient is shifted to theatre for 
haematoma evacuation and ligating bleeding vessel 
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Respiratory obstruction 
 Most cases are due to laryngeal oedema. Tension haematoma is the 
important cause. If the goitre is very large, laryngeal odema develops due 
to injury to larynx during intubation.  Immediate postoperative respiratory 
obstruction is not due to recurrent laryngeal nerve injury. If airway 
obstruction is not relieved by releasing tension haematoma, patient should 
be intubated at once.   An endotracheal tube may be left in place for 
several days; to reduce laryngeal oedema, steroids can be given. 
Postoperative thyroid crisis  
 It is due to inadequate preparation of the patient before surgery. It 
is characterized by tachycardia, high fever, restlessness and delirium, 
progressing towards cardiac failure. Supportive treatment is given for 
dehydration, hyperpyrexia and restlessness. This requires administration 
of oxygen, intravenous fluids, cooling the patient with icepacks and, 
digoxin for uncontrolled atrial fibrillation, sedation and intravenous 
hydrocortisone. Specific treatment – 
carbimazole 10-20 mg 6 hourly,  
lugol’s iodine 10 drops 8 hourly by mouth or  
Sodium iodide 1 gm intravenously 
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 Propronalol 40 mg 6 hourly orally will block adverse beta 
adrenergic effects. 
PARATHYROID INSUFFICIENCY 
 This is due to parathyroid glands removal or trauma to parathyroid 
end artery. The incidence of this condition is less than 0.5% and most 
cases will present 2-5 days after operation, but very rarely the onset is 
delayed for 2-3 weeks or a patient with marked hypocalcaemia is 
asymptomatic. It is commonly transient in nature and quickly controlled 
by calcium by mouth. If severe, 20 ml of 20% solution of calcium 
gluconate is given intravenously i.e, (10 ml of 10% ampoule) and later 
supplemented with oral calcium. 
RECURRENT LARYNGEAL NERVE PARALYSIS 
 This may be unilateral or bilateral, transient or permanent. 
Transient paralysis occurs in about 3% of cases and recovers in about  
3 weeks to 3 months. Permanent paralysis is rare if the nerve has been 
identified at operation. If recovery does not take place within this period, 
organic injury to the nerve should be suspected. This may be due to 
stretching or bruising of the nerve or to its inclusion in a ligature, it is 
seldom divided. The prognosis regarding the recovery of function is poor 
if the nerve is divided. Repair of the nerve may be attempted, but the 
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results are uncertain. Roberto Berganiaschi et al33 in a study conducted 
in France, including 192 thyroidectomies during 50 months with a follow 
up of 8.56 months gave the following inference regarding complications: 
 Death – 0.08%, Haematoma-1.6%, Chyle leak – 0.2%, Abscess –
0.5% 
•  Temporary and permanent hypoparathyroidism – 20% and 4% 
respectively. Temporary and permanent recurrent laryngeal nerve 
palsy – 2.9% and 0.5% respectively. Chung Yau Lo et al34 in a 
study on 500 thyroidectomies in Hong Kong observed incidence of 
temporary and permanent recurrent laryngeal nerve palsy as 5.2% 
and 1.4% respectively. 
 Garanni Sturniolo et al34 in a study on 192 thyroidectomies in Italy 
observed one case (0.5%)_ of recurrent laryngeal nerve injury due to 
neoplastic infiltration, one case (0.5%) of unilateral cordal hypo motility 
and two (1.04%) of bilateral hypo motility with temporary dysphonia, 
which regressed in 6 months of time. 
Hypothyroidism 
 Hypothyroidism occurs within 2 years, may be delayed for 5years 
or more. Hypothyroidism commonly follows after subtotal thyroidectomy 
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for lymphocytic thyroiditis. The treatment consists of administration of L- 
Thyroxine 0.1mg to prevent myxedema after analyzing thyroid profile 
post operatively at 1 week and 1 month. 
Recurrent thyrotoxicosis 
 This is due to either removal of inadequate thyroid tissue or to 
subsequent hyperplasia of the tissue that has been left. It is not 
uncommon in primary toxic goitre but very rare in the secondary 
thyrotoxicosis. Further operation should be avoided if possible. The best 
results are obtained by radioiodine or by the anti-thyroid drugs. 
Other complications 
These include: 
• Wound infection, Hypertrophic or Keloid Scar, Stitch granuloma 
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EXPOSURE  OF PRETRACHEAL FASCIA  IN FRONT OF 
THYROID 
 
RETRACTING STRAP MUSCLES AND EXPOSING LOBES OF 
THYROID 
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LIGATION OF SUPERIOR PEDICLE 
 
INDENTIFYING  RECURRENT  LARYNGEAL NERVE 
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TOTAL THYROIDECTOMY-SPECIMEN 
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MATERIALS AND METHODS 
 The material of the present study consists of patients admitted with 
nodular thyroid swelling from July 2010 to August 2012 at the surgical 
units of Government Royapettah hospital, Kilpauk medical college. 
Totally, 50 patients were admitted and treated during this period. Among 
these, 43 patients were female, and remaining 7 were males. After 
admission, a detailed history was taken and thorough clinical examination 
was carried out which was entered in the proforma. The patients were 
investigated. The investigations included Haemoglobin percentage, urine 
analysis, blood sugar estimation, blood urea estimation, blood grouping 
and Rh typing, serum cholesterol, x-ray of the neck-AP and lateral views 
and chest X-ray and ENT examination. All patients had a Thyroid profile 
and FNAC done. These patients underwent surgery and all the excised 
thyroid specimen were sent for histopathological examination. Patients 
were discharged after removing the sutures and were asked to come for 
follow up. Post-operative thyroid profile was done on 1st post-operative 
week and at 1 month. They were advised to take the needful medications 
accordingly. Only those patients with clinical evidence of multinodular 
goitre were taken up for the study randomly, excluding malignancies 
detected preoperatively and the results were compared with other studies. 
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 For all patients whose HPE – Reported as benign were treated with 
replacement dose of thyroxine and followed up. For one case whose HPE 
come as maligancy was treated with suppressive dose of thyroxine and 
followed up with thyroglobulin measurement and radioactive iodine scan. 
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OBSERVATION 
 
Period of Study: July 2010 to August 2012. 
Total Number of cases: 50 
Age group: 17 to 60 years 
Average age group of Patient: 35 years. 
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TABLE 1 
AGE AND SEX INCIDENCE 
AGE IN 
YRS 
MALE FEMALE TOTAL PERCENTAGE 
0-10 00 00 00 00 % 
11-20 00 02 02 04% 
21-30 01 14 15 30% 
31-40 01 14 15 30% 
41-50 02 09 11 22% 
51 & 
ABOVE 
03 04 07 14% 
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TABLE 2 
DURATION OF SWELLING 
DURATION  OF  
SWELLING 
TOTAL  NO  OF   
CASES 
PERCENTAGE 
1-6 MONTHS 22 44 % 
6-12 MONTHS 10 20% 
1-2  YEARS 8 16% 
2-5  YEARS 8 16% 
5-10  YEARS 2 4% 
          TOTAL 50 100% 
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TABLE 3 
PROGRESSION OF THYROID SWELLING 
 
PROGRESSION  OF  
SWELLING 
TOTAL NO  OF 
CASES 
PERCENTAGE 
GRADUAL  49 98% 
 
RAPID 1 2% 
TOTAL 50 100% 
 
PROGRESSION OF SWELLING 
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TABLE 4 
INCIDENCE OF PAIN IN THYROID SWELLING 
PAIN  IN  
SWELLING 
TOTAL NO OF  
CASES 
PERCENTAGE 
PAINLESS  
SWELLING 
 
46 92% 
PAINFULL  
SWELLING 
4 8% 
TOTAL 50 100% 
 
INCIDENCE OF PAIN 
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TABLE 5 
INCIDENCE OF PRESSURE SYMPTOMS 
SYMPTOMS TOTAL NO OF  
CASES 
PERCENTAGE 
Pressure symptoms   
a)hoarseness of voice    0 00% 
b)difficulty in 
swallowing 
    4 08% 
c)dypsnea 0 00% 
No  pressure 
symptoms 
46 92% 
TOTAL 50 100% 
 
                            PRESSURE SYMPTOMS 
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TABLE 6 
INCIDENCE OF TOXICITY 
 
TOXICITY MALE FEMALE TOTAL PERCENTAGE 
With toxicity 2 11 13 26% 
Without toxicity 5 32 37 74% 
 
INCIDENCE OF TOXICITY 
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TABLE 7 
SITUATION OF LOWER BORDER OF THYROID SWELLING 
 
LOWER BORDER TOTAL NO OF  
CASES 
PERCENTAGE 
Lower border  seen                 50 100% 
Lower border not seen                 00 00% 
 
TABLE 8 
INCIDENCE OF TRACHEAL SHIFT 
TRACHEAL 
POSITION 
TOTAL NO OF 
CASES 
PERCENTAGE 
Trachea central 48 96% 
Trachea shifted  to  
right 
2 4% 
Trachea shifted to left  0 00% 
Total 50 100% 
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TABLE 9 
FNAC OF THYROID SWELLING 
FNAC  - REPORT TOTAL NO OF  
CASES 
PERCENTAGE 
Colloid  goitre 44 88% 
Hashimoto’s 
thyroiditis 
4 8% 
Follicular neoplasm 
 
2 4% 
Malignancy 
 
00 00% 
In conclusive 00 00% 
TOTAL 50 100% 
  
                                      FNAC- THYROID 
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TABLE 10 
HISTOPATHOLOGY(HPE) OF THYROIDECTOMY   SPECIMEN 
HPE  REPORT TOTAL NO OF 
CASES 
PERCENTAGE 
Colloid  goitre 43 86% 
Hashimoto’s 
thyroiditis 
4 8% 
Follicular  adenoma 2 4% 
Papillary  carcinoma 1 2% 
TOTAL 50 100% 
 
HPE OF THYROID SPECIMEN 
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TABLE 11 
COMPLICATIONS OF THYROID SURGERY 
 
COMPLICATIONS TOTAL NO OF 
CASES 
PERCENTAGE 
Reactionary  
haemorrhage 
00 00% 
Transient  
hypoparathyroidism 
3 
 
6% 
Recurrent  laryngeal 
nerve palsy 
00 00% 
Wound  infection 00 00% 
 
COMPLICATIONS  OF SURGERY 
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DISCUSSION 
 
 Fifty patients presenting with multinodularity of the thyroid gland 
without obvious evidence of malignancy were studied and evaluated in 
terms of history, clinical examination and subjected for relevant 
investigations, taken up for surgery with prior FNAC and histopathology 
of operated specimen done post operatively. The results were analysed as 
depicted in the table 1 to table 12. Of the fifty cases studied, 7 were males 
(14 %) and 43 were females (86%) with a female to male ratio of 6:1. 
Antonio Rios et al (2004) showed that 89% were females. In the study 
conducted in King George Hospital in Vishakapatnam, female to male 
ratio was 5:1. Table 1 shows the age and sex distribution of the patients 
studied. 42.8% (3 cases) of the males presented in the age group of 51 
years and above. Whereas among females 14 cases presented in the age 
group of 21 – 30 and 14  female cases in the age group of  31 – 40 years . 
Majority of the females 56 %, (28 cases) presented in the age group 
between 21 – 40 years. But in the western literature quoted by “Bremer 
and Moll Night” in analysis of 1280 cases of multinodular goitre, the age 
incidence was maximum between 40 – 49 years. Hence the average age 
incidence in our study is low compared to western series. In our study 
maximum age of presentation was 57 years and minimum age was 17 
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years with an average age incidence of 35 Years. During our study 
period, totally 90 thyroid surgeries were done for various diseases of the 
thyroid. Multinodular goiter was the commonest indication for surgery 
with 50 cases. The Chief complaint in our patients (100 %) was swelling 
in front of the neck. However few patients had associated local symptoms 
like difficulty in swallowing. Duration of swelling ranged from 1 month 
to 10 years and 96% (48 cases) were seen in the range of 1 month to 5 
years. The size of the swelling increased gradually in 49cases (98%), 
rapidly in 1 case (2%). The case, which showed rapid increase in size, 
was not malignant, and did not give rise to any pressure symptoms. Most 
of the swellings – 46 cases (92%) were not associated with pain and only 
4 cases (8%) had pain. Pressure symptoms were seen in 8% (4 cases) as 
against 29% in Antonio rios et al (2004) study. In our study 4 cases (8 %) 
presented with difficulty in swallowing. Thus difficulty in swallowing 
was the commonest pressure symptom. Toxic symptoms and signs were 
seen in 13 cases (26 %), which included 11 female (22%) and 2 males 
(4%). Among these 2 female patients had eye signs and 11 patients had 
tremors of hands and tongues, and tachycardia. Toxic symptoms were 
seen in 49% of cases in Antonio Rios et al (2004) study. 
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 All thyroid swellings in our study were moving with deglutition. 
Both lobes were involved in 50 cases. In majority of the patients the size 
the gland was in stage 2 according to WHO classification i.e. swelling 
visible with neck in normal position. The clinical features of the nodule 
were not helpful in the diagnosis of malignancy. There was no correlation 
between the consistency, duration and size of the nodules and 
malignancy. 
 X-ray of neck, AP and lateral views and X-ray of the chest were 
done in all the cases. There was one case of tracheal shift to right side due 
to a goitre, mainly involving left lobe of the thyroid. FNAC of the thyroid 
was done in all the cases and the results compared with histopathological 
report of operated specimen.  Two cases of follicular neoplasms came as 
follicular adenoma on histopathology. Diagnosis of Follicular carcinoma 
preoperatively by FNAC was not possible as angioinvasion and capsular 
invasion, which are features of Follicular carcinoma, were not evident. 
This shows that FNAC is not 100% accurate in the diagnosis of follicular 
carcinoma. 
The advantages of FNAC are: 
1.  It is safe and fairly accurate method for establishing whether MNG 
is a benign or malignant. Surgery can be avoided in many patients 
with benign disease. 
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2.  Complications of FNAC are negligible and patient acceptance is   
high. 
3.  It requires no anaesthesia. 
The disadvantages of FNAC are: 
1.  It is not 100% accurate. 
2.  It cannot distinguish between benign from malignant follicular  
neoplasms. 
 We had 4 cases of MNG with thyroiditis and were operated. The 
two cases of follicular neoplasms were operated to rule out follicular 
carcinoma. Total  thyroidectomy was done for  all 50  cases In our study 
postoperative complications were very few. Transient 
hypoparathyroidism was seen in 3 patients (6%) which was observed 
during the first post-operative week and all recovered completely with 
oral calcium and I.V. calcium therapy. There was no permanent 
hypoparathyroidism. T.A. Day et al (2003) shows that there was 28% of 
temporary hypocalcemia and 0.9% with permanent hypocalcemia. There 
was no mortality in our series. 
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SUMMARY AND CONCLUSIONS 
 Fifty patients of MNG were evaluated with respect to age, sex, 
duration of swelling and were investigated with FNAC. Operated 
specimen subjected to histopathological examination and results were 
analysed. 
1.  MNG is the commonest thyroid disease in our hospital. 
2.  Multinodular goiter is more common in females (Female to male 
ratio 6:1) majority are in the age group of 21-40 years (56%). 
3.  The chief complaint in majority of the patients is swelling in front 
of the neck and few patients with pressure symptoms. 
4.  In majority (90%) of the patients, duration of the swelling prior to 
presentation was 6 months to 5 years. 
5.  Secondary thyrotoxicosis is seen in 26% (13 cases) 
6.  FNAC is very useful in the diagnosis and management of MNG. 
7.  Malignancy can still come as a surprise on post-operative 
histopathological examination, even when there is no suspicion of 
malignancy clinically and with FNAC. 
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8.  The main indications of surgery in MNG are secondary 
thyrotoxicosis, risk of MNG turning into milignancy, pressure 
effect symptoms and cosmetic problem. 
9.  Total thyroidectomy is the surgery of choice for MNG.  
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ANNEXURES 
LIST OF ABBREVATIONS USED 
 
AEIA   --  Amplified enzyme linked immunoassay 
CT   --  Computerised tomography 
DIT   --  Di iodotyrosine 
DMSA  --  Di mercapto succinic acid 
FNAC  --  Fine needle aspiration cytology 
FT4   --  Free thyroxine 
FT3   --  Free tri iodothyronine 
FT4I   --  Free thyroxine index 
FT3I   --  Free tri iodothyronine index 
HPE   --  Histopathological examination 
IRMA  --  Immuno radiometric assay 
LATS  --  Long acting thyroid stimulators 
MNG  --  Multinodular goiter 
MIT   --  Mono iodo tyrosine 
NMRI  --  Nuclear magnetic resonance imaging 
PAS   --  Para amino salicylic acid 
PBI   --  Protein bound iodine 
RAIU  --  Radioactive iodine uptake 
RSG   --  Retrosternal goiter 
T4   --  Thyroxine 
T3   --  Tri iodo thyronine 
TBA   --  Thyroxine binding albumin 
TBBA  --  Thyroxine binding pre albumin 
TBC   --  Thyroxine binding capacity 
T3RU  --  Tri iodo thyronine radio iodine uptake 
TSH   --  Thyroid stimulating hormone 
TRAbs --  Thyroid receptor antibodies 
TRH   --  Thyrotropin releasing hormone 
TSAbs --  Thyroid stimulating antibodies 
TSI   --  Thyroid stimulating antibodies 
WHO  --  World health organization 
  PROFORMA 
Name :    Age :   Sex:   
Inpatient No. :   Unit/ward:   Occupation:   
Socioeconomic status :  
Address   :  
Date of Admission  :        
Date of operation  :      
Date of Discharge  :  
Presenting complaints :  
1.  Swelling in the thyroid region/ duration/ progress.  
2.  Pain in the swelling.  
3.  Difficulty in swallowing and breathing.  
4.  Change in voice.  
5. Other symptoms.  
6. Toxic symptoms.  
a) Anxiety/ nervousness.  
b) Dyspnoea  
c) Sweating  
d)  Intolerance to heat/ cold  
e) Palpitation  
f) Weight loss  
g) Diarrhea  
h)  Increase/ decrease of appetite  
i) Menstrual disturbances- menorrhagea/ oligomenorrhea  
History of present illness:  
 Onset      Duration  
 Progress     Size  
 Pain      Fever  
 Dyspnoea     Dysphagia  
  Change in voice        Symptoms of hyper/hypo features  
  Any other symptoms                         
  Past history:   
1.  Whether from endemic area  
2.  Ingestion of goitrogenic food materials  
3.  Ingestion of goitrogenic or ATT drugs  
4.  Irradiation of neck  
5. Others.  
Family history:  
1.  History of thyroid swelling in the family.  
2.  Marital status and children.  
3. Diabetes/ hypertension/ malignancies.  
Personal history:   
1. Diet 2. Appetite 3. Sleep 4. Bowel/ bladder  5. Habits  
Treatment history:   
History of taking anti thyroid drugs/ thyroxine/ oral contraceptives/ 
surgery.  
General physical examination:   
1.   Appearance ( anxious, ill etc)  
2.  Build/ nourishment  
3.  Anemia  
4.  Generalized lymphadenopathy  
5.   Hands – warm/ moist/ cold  
6.   Tremors – hands/ tongue  
7.   Vital signs   - pulse  
- BP  
- temperature  
- respiratory rate  
8.   Sleeping pulse rate  
9.  Eye signs  
 Local examination:  
1.  Inspection:  
   Site of the swelling   
   Size/ shape/ surface/ extension.   
   Skin over the swelling/ veins/ pulsations   
   Borders   
   Movement with deglutition   
2.  Palpation:  
   Site/ size/ shape/ surface/ extension /   confirmation of inspectory  
   findings  
  Borders  
  Mobility/ plane/ thrill/ fluctuation/ transillumination/ lower border  
  Tenderness/ consistency/ local rise of temperature  
  Palpation of carotid pulsations  
  Tracheal position  
  Regional lymph nodes  
3.   Percussion:   
Over manubrium steni for retrosternal extension.  
4.   Auscultation:   
For bruit/ murmurs over the gland.  
Examination of other systems:  
  Cardiovascular system,    Respiratory system,   Central nervous system ,  
  Per abdominal examination,    Examination for eye signs .  
Clinical diagnosis:  
Investigations:   
 HB    Blood grouping and cross mathing  
 TC    Blood urea  
 DC    Serum creatinine  
 ESR    Serum cholesterol  
 Blood sugars   Serum calcium  
  Urine routine      Thyroid profile- T3, T4, TSH ,  Chest x ray  
  Neck x ray- AP and lateral view  
 ECG , Indirect laryngoscopy , FNAC  
Final diagnosis:  
Pre operative management:  
  (Drugs to control toxicity if present/ diabetes mellitus/ hypertension/ 
heart diseases etc.)  
Surgery performed and operative findings:  
Post operative complications and their management:  
Histopathology report of the excised specimen:  
Follow up: 
 
 
KEY TO MASTER CHART 
Age –Ageinyears, M –Male, F -Female 
Mn - Months , D – Days,  DIB - Difficulty in breathing 
DIS - Difficulty in swallowing, A - Absent, P - Present 
N – Normal,  C - Central , BL - Both lobes equally involved 
IDL - Indirect laryngoscopy,  T3 - Tri iodothyronine ,  T4 - Thyroxine  
TSH - Thyroid stimulating hormone 
           ↑ - Increased,↓ – Decreased 
 CG - Colloid goiter, HT- Hashimotos thyroiditis 
 FN - Follicular neoplasm,  FA - Follicular adenoma  
 P CA - Papillary carcinoma,  FNAC - Fine needle aspiration cytology, 
 TT - Total thyroidectomy,  MNG - Multinodular goiter  
 HPE - Histopathological examination report 
 
 
 
 
 
 
MASTER CHART  
 
PARTICULARS OF PATIENT CLINICAL FEATURES  INVESTIGATIONS FOLLOW UP 
S 
no Name 
Age/S
ex Ip no duration 
Pa
in 
D
I
B
DI
S 
Change 
in voice 
Lobes 
involv
ed 
Toxic 
featu
res 
Tracheal 
position T3 T4 
TS
H 
I
D
L 
FNAC Surgery Complications HPE 
Post op 
IDL 
1 Selvi 28/f 975143 5 mn A A A A BL A C N N N N CG TT A CG N 
2 kamala 32/f 976214 8mn A A A A BL A C N N N N CG TT A CG N 
3 Eswari 26/f 977153 1yr A A A A BL A C N N N N CG TT A CG N 
4 Danam 31/f 976853 3mn A A A A BL A C N N N N CG TT A CG N 
5 Rajeswari 34/f 977134 2mn A A A A BL P C ↑ ↑ ↓ N CG TT TETANY CG N 
6 Mallika 25/f 978563 6mn A A A A BL A C N N N N CG TT A CG N 
7 Vani 40/f 978667 7mn A A A A BL A C N N N N CG TT A CG N 
8 Logeswari 29/f 976859 9mn A A A A BL P C ↑ ↑ ↓ N FN TT A FA N 
9 Sembagam 23/f 979873 3mn P A A A BL A C N N N N HT TT A CG N 
10 Kumar 24/m 978123 5mn A A A A BL A C N N N N CG TT A CG N 
11 Kavipriya 35/f 979811 3yr A A A A BL P C ↑ ↑ ↓ N CG TT A CG N 
12 Vimala 37/f 976524 4yr A A A A BL A C N N N N CG TT A CG N 
13 Jeeva 28/f 977568 4mn P A A A BL P C ↑ ↑ ↓ N HT TT A CG N 
14 Anbarasi 34/f 976541 6mn A A A A BL A C N N N N CG TT A CG N 
15 Kaliammal 29/f 978975 7mn A A A A BL A C N N N N CG TT A CG N 
16 Thamarai 32/f 987532 10mn A A A A BL P C ↑ ↑ ↓ N FN TT A FA N 
17 Muniammal 38/f 987521 5mn A A A A BL A C N N N N CG TT A CG N 
18 Chitra 40/f 988641 2mn A A A A BL A C N N N N CG TT A P CA N 
19 Karpagam 27/f 986123 3mn A A A A BL A C N N N N CG TT A CG N 
20 Saraswathi 25/f 985126 2mn A A A A BL P C ↑ ↑ ↓ N CG TT TETANY CG N 
21 pushpa 34/f 988651 5mn A A A A BL A C N N N N CG TT A CG N 
22 Jothi 31/f 987641 1.5yr A A A A BL A C N N N N CG TT A CG N 
23 Geetha 38/f 986872 4mn A A A A BL A C N N N N CG TT A CG N 
24 Valliammal 33/f 985438 8mn A A A A BL A C N N N N CG TT A CG N 
25 Moorthi 55/m 987652 9mn A A A A BL A C N N N N CG TT A CG N 
26 Dinesh 38/m 986421 8mn A A A A BL P C ↑ ↑ ↓ N CG TT A CG N 
27 Kalaiselvi 52/f 987512 4mn A A A A BL A C N N N N CG TT A CG N 
28 Arul 43/m 986987 3yr A A A A BL P C ↑ ↑ ↓ N CG TT A CG N 
29 Saroja 26/f 985731 3mn A A A A BL A C N N N N CG TT A CG N 
PARTICULARS OF PATIENT CLINICAL FEATURES  INVESTIGATIONS FOLLOW UP 
S 
no Name 
Age/S
ex Ip no duration 
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L 
FNAC Surgery Complications HPE 
Post op 
IDL 
30 Renuka 25/f 985762 5mn A A A A BL P C ↑ ↑ ↓ N CG TT A CG N 
31 Aarthi 29/f 989123 2mn A A A A BL A C N N N N CG TT A CG N 
32 Jebasharun 27/f 985743 3mn A A A A BL A C N N N N CG TT A CG N 
33 Janani 55/f 989431 6yr A A P A BL A C N N N N CG TT A CG N 
34 Anand 52/m 989534 4yr A A A A BL A C N N N N CG TT A CG N 
35 Lavanya 58/f 989438 8mn A A A A BL A C N N N N CG TT A CG N 
36 Rengasamy 46/m 987421 7yr A A P A BL A R N N N N CG TT A CG N 
37 Gayathri 19/f 986589 3mn A A A A BL A C N N N N CG TT A CG N 
38 Bhuvaneshwari 17/f 992732 5mn P A A A BL A C N N N N HT TT A CG N 
39 Noorjahan 42/f 993421 7mn A A A A BL A C N N N N CG TT A CG N 
40 Elumalai 57/m 994562 3.5yr A A A A BL A C N N N N CG TT A CG N 
41 Lalitha 49/f 995671 4yr A A P A L A R N N N N CG TT A CG N 
42 Sarasu 45/f 992871 1yr A A A A L A C N N N N CG TT A CG N 
43 Shamili 46/f 995648 1.5yr A A A A BL A C N N N N CG TT TETANY CG N 
44 Ellammal 44/f 996731 2yr A A A A BL A C N N N N CG TT A CG N 
45 Uma 43/f 102431 3yr A A P A BL P C ↑ ↑ ↓ N CG TT A CG N 
46 Bharathi 48/f 103482 5yr A A A A BL A C N N N N CG TT A CG N 
47 Kumari 49/f 104531 2yr A A A A L A C N N N N CG TT A CG N 
48 Ponni 41/f 102465 1yr A A A A BL A C N N N N CG TT A CG N 
49 Lakhsmi 53/f 101743 2yr A A A A L A C N N N N CG TT A CG N 
50 kanimozhi 29/f 108794 3mn P A A A BL P C ↑ ↑ ↓ N HT TT A CG N 
 
